Inside Mount Sinai

In this issue:

  • James Ferrara, MD, is leading a world-class research program at Mount Sinai to treat graft-versus-host disease, a serious complication of bone marrow transplantation.

  • Ron Shapiro, MD, joins Mount Sinai’s Recanati Miller Transplantation Institute as the new Surgical Director of the Kidney and Pancreas Transplant Program.

  • Mount Sinai researchers, under Adolfo Garcia-Sastre, PhD, have identified 53 FDA-approved drugs that may help fight the Ebola virus.

  • The Mount Sinai Health System has partnered with Empire BlueCross BlueShield to manage all aspects of care for Empire’s 48,000 commercial and Medicare members.

  • Kristjan Ragnarsson, MD, has received a lifetime achievement award from the American Academy of Physical Medicine and Rehabilitation.

  • Mount Sinai Health System nurses were recognized for extraordinary achievements in a Tribute to Nurses, the special New York Times Magazine advertising section; STRIVE has named Mount Sinai an Outstanding Partner of the Year for its efforts in hiring East Harlem residents; and Will Parker, a security worker at Mount Sinai Beth Israel, is also a singer and composer who performs at fine hotels in New York City. On February 2, he will perform on the Mount Sinai Beth Israel campus.

View the PDF